Compare · EMR vs PBAX
EMR vs PBAX
Side-by-side comparison of Emerson Electric Company (EMR) and Phoenix Biotech Acquisition Corp. (PBAX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EMR operates in Technology, while PBAX operates in Industrials - the two are in different parts of the market.
- EMR carries a market cap of $91.57B.
- EMR has hit the wire 40 times in the past 4 weeks while PBAX has been quiet.
- EMR has more recent analyst coverage (25 ratings vs 0 for PBAX).
- Company
- Emerson Electric Company
- Phoenix Biotech Acquisition Corp.
- Price
- -
- -
- Market cap
- $91.57B
- -
- 1M return
- +3.77%
- -
- 1Y return
- +30.05%
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 40
- 0
- Recent ratings
- 25
- 0
Emerson Electric Company
Emerson Electric Co. designs and manufactures technology and engineering products for industrial, commercial, and consumer markets worldwide. It operates through Automation Solutions and Commercial & Residential Solutions segments. The Automation Solutions segment offers measurement and analytical instrumentation, industrial valves and equipment, and process control software and systems. It serves the oil and gas, refining, chemicals, power generation, life sciences, food and beverage, automotive, pulp and paper, metals and mining, and municipal water supplies markets. The Commercial & Residential Solutions segment offers residential and commercial heating and air conditioning products, such as residential and variable speed scroll compressors; system protector and flow control devices; standard, programmable, and Wi-Fi thermostats; monitoring equipment and electronic controls for gas and electric heating systems; gas valves for furnaces and water heaters; ignition systems for furnaces; sensors and thermistors for home appliances; and temperature sensors and controls. It also provides reciprocating, scroll, and screw compressors; precision flow controls; system diagnostics and controls; and environmental control systems for use in medical, food processing, and cold storage applications. In addition, this segment offers air conditioning, refrigeration, and lighting control technologies, as well as facility design and product management, site commissioning, facility monitoring, and energy modeling services; temperature management and monitoring products for the foodservice markets; and professional and homeowner tools, and appliance solutions. The company was formerly known as The Emerson Electric Manufacturing Company and changed its name to Emerson Electric Co. in 2000. Emerson Electric Co. was founded in 1890 and is headquartered in St. Louis, Missouri.
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest EMR
- Emerson Electric Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Emerson Electric Company
- President & CEO Karsanbhai Surendralal Lanca covered exercise/tax liability with 10,016 shares, decreasing direct ownership by 3% to 282,136 units (SEC Form 4)
- Executive Vice Pres & COO Krishnan Ram R. covered exercise/tax liability with 4,293 shares, decreasing direct ownership by 4% to 98,708 units (SEC Form 4)
- Exec VP, CFO & CAO Baughman Michael J covered exercise/tax liability with 2,003 shares, decreasing direct ownership by 1% to 145,469 units (SEC Form 4)
- Chief Technology Officer Zornio Peter covered exercise/tax liability with 480 shares, decreasing direct ownership by 0.70% to 67,646 units (SEC Form 4)
- SVP & Chief Sustain Officer Train Michael H. covered exercise/tax liability with 1,431 shares, decreasing direct ownership by 0.58% to 244,918 units (SEC Form 4)
- Senior VP & CCO Flavin Lisa covered exercise/tax liability with 1,002 shares, decreasing direct ownership by 0.97% to 101,857 units (SEC Form 4)
- Senior VP &CMO Ramnath Vidya covered exercise/tax liability with 293 shares, decreasing direct ownership by 0.66% to 43,939 units (SEC Form 4)
- Senior VP & CPO Piazza Nicholas J. covered exercise/tax liability with 859 shares, decreasing direct ownership by 2% to 39,830 units (SEC Form 4)
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)